Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 COX-2 and beyond: Approaches to prostaglandin inhibition in human disease.

× No keyword cloud information.

114 in total

1. Gene expression profile of coronary artery cells treated with nonsteroidal anti-inflammatory drugs reveals off-target effects.

Authors: Sanjeewani T Palayoor; Molykutty J-Aryankalayil; Adeola Y Makinde; David Cerna; Michael T Falduto; Scott R Magnuson; C Norman Coleman
Journal: J Cardiovasc Pharmacol Date: 2012-06 Impact factor: 3.105

2. Serum concentrations of cyclooxygenase-2 in patients with systemic sclerosis: association with lower frequency of pulmonary fibrosis.

Authors: Iman H Bassyouni; Roba M Talaat; Tarek A Salem
Journal: J Clin Immunol Date: 2011-10-07 Impact factor: 8.317

3. Nrf2 is essential for the expression of lipocalin-prostaglandin D synthase induced by prostaglandin D2.

Authors: Kyun Ha Kim; Ruxana T Sadikot; Lei Xiao; John W Christman; Michael L Freeman; Jefferson Y Chan; Yu-Kyoung Oh; Timothy S Blackwell; Myungsoo Joo
Journal: Free Radic Biol Med Date: 2013-09-09 Impact factor: 7.376

4. Transgenic insulin-like growth factor-1 stimulates activation of COX-2 signaling in mammary glands.

Authors: Jie Tian; Isabel Lambertz; Thomas R Berton; Joyce E Rundhaug; Kaoru Kiguchi; Stephanie H Shirley; John Digiovanni; Claudio J Conti; Susan M Fischer; Robin Fuchs-Young
Journal: Mol Carcinog Date: 2011-10-17 Impact factor: 4.784

Review 5. Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities.

Authors: Tilo Grosser; Susanne Fries; Garret A FitzGerald
Journal: J Clin Invest Date: 2006-01 Impact factor: 14.808

6. Understanding the COX-2/NSAID dilemma.

Authors: Sanford H Roth
Journal: Drugs Date: 2005 Impact factor: 9.546

7. The effect of eicosapentaenoic and docosahexaenoic acids on physical function, exercise, and joint replacement in patients with coronary artery disease: A secondary analysis of a randomized clinical trial.

Authors: Abdulhamied Alfaddagh; Tarec K Elajami; Mohamad Saleh; Mohamad Elajami; Bruce R Bistrian; Francine K Welty
Journal: J Clin Lipidol Date: 2018-03-14 Impact factor: 4.766

COX-2 and beyond: Approaches to prostaglandin inhibition in human disease.